Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2017; 17(6):466-469
DOI: 10.5428/pcar20170619
Investigation on the supervision mode in the application of adjuvant drugs in hospitals
1. XUE HongLin1(1.Department of Pharmacy,No. 175 Hospital of PLA/Southeast Hospital Affiliated to Xiamen University,Fujian Zhangzhou 363000,China asctx472@126.com)
2. YANG TianXu2(2.College of Pharmacy,Fujian Medical University,Fuzhou 350000,China )
3. FEI Yan1(1.Department of Pharmacy,No. 175 Hospital of PLA/Southeast Hospital Affiliated to Xiamen University,Fujian Zhangzhou 363000,China 1.Department of Pharmacy,No. 175 Hospital of PLA/Southeast Hospital Affiliated to Xiamen University,Fujian Zhangzhou 363000,China)
ABSTRACT  Objective: To develop standardized supervision methods and explore effective supervision mode in the application of adjuvant drugs,so as to provide evidence for the reduction of drug use percentage.Methods: The supervision mode of adjuvant drugs was developed,including drug category management,medication management,prescription review,auxiliary examination and evaluation system,and reward and punishment system as well.This facilitated a sound evaluation on drug use percentage,total cost of adjuvant drugs,average cost per capita and rate of irrational medication concerning supervision efficiency.Results: The supervision mode in the application of adjuvant drugs worked well,enabling drug use percentage,total cost of adjuvant drugs,average cost per capita and rate of irrational medication to decrease considerably,and good results were thus achieved.Conclusion: The supervision mode of adjuvant drugs in the hospital was feasible.However,further efforts were required for the perfection of the supervision mode.
Welcome to PCAR! You are the number 323 reader of this article!
Please cite this article as:
XUE HongLin1,YANG TianXu2,FEI Yan1,. Investigation on the supervision mode in the application of adjuvant drugs in hospitals[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2017; 17(6): 466-469.
References:
1. HAN Rong,ZHAO ZhiGang.Discussion on how to strengthen the adjuvant drug management in medical institutions[J].Drug Eval,2016,13(4):21-25.In Chinese with English abstract.
2. ZHONG MinTao,HAN Shuang,ZHANG Lu,et al.Research of adjuvant drugs in medical institutions in China based on Delphi method[J].Chin Hosp Pharm J,2016,36(19):1621-1624.In Chinese with English abstract.
3. WANG Li,CAI DeFang,CHEN Yong,et al.Study on classification methods of adjuvant drugs[J].China Pharmacist,2015,18(12):2156-2159.In Chinese with English abstract.
4. WANG Zheng,LI Fang,CHENG Jing,et al.Observation on the efficacy of monosialotetrahexosylganglioside sodium injection combined with brain protein hydrolysate for the treatment of Parkinson disease[J].Chin J Biochem Pharm,2012,33(6):858-860.In Chinese with English abstract.
5. SHU Yang,YANG Yi,GAO TianXing,et al.Exploration of ward medication orders audit mode based on clinical pharmacist information management system[J].Pharm Care Res,2017,17(1):54-57.In Chinese with English abstract.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口